Your browser is no longer supported. Please, upgrade your browser.
Settings
NVAX Novavax, Inc. daily Stock Chart
NVAX [NASD]
Novavax, Inc.
Index- P/E- EPS (ttm)-0.77 Insider Own0.30% Shs Outstand296.75M Perf Week0.00%
Market Cap338.29M Forward P/E- EPS next Y-0.56 Insider Trans17.42% Shs Float290.07M Perf Month14.00%
Income-211.70M PEG- EPS next Q-0.16 Inst Own43.10% Short Float18.46% Perf Quarter0.88%
Sales21.00M P/S16.11 EPS this Y-72.80% Inst Trans-9.90% Short Ratio8.40 Perf Half Y-6.56%
Book/sh-0.21 P/B- EPS next Y9.70% ROA-53.90% Target Price1.78 Perf Year-23.49%
Cash/sh0.63 P/C1.81 EPS next 5Y0.00% ROE- 52W Range0.73 - 2.47 Perf YTD-9.52%
Dividend- P/FCF- EPS past 5Y-43.40% ROI- 52W High-53.85% Beta1.95
Dividend %- Quick Ratio3.50 Sales past 5Y0.90% Gross Margin- 52W Low56.16% ATR0.05
Employees355 Current Ratio3.50 Sales Q/Q168.00% Oper. Margin- RSI (14)48.32 Volatility4.79% 4.51%
OptionableYes Debt/Eq- EPS Q/Q46.50% Profit Margin- Rel Volume0.74 Prev Close1.12
ShortableYes LT Debt/Eq- EarningsAug 08 AMC Payout- Avg Volume6.38M Price1.14
Recom2.60 SMA204.11% SMA502.94% SMA200-3.13% Volume4,732,636 Change1.79%
Aug-09-17Upgrade Ladenburg Thalmann Neutral → Buy
Sep-20-16Reiterated Chardan Capital Markets Neutral $5.75 → $1.50
Sep-16-16Reiterated FBR & Co. Outperform $17 → $12
Sep-16-16Downgrade Wedbush Outperform → Neutral $14 → $2
Sep-16-16Downgrade Piper Jaffray Overweight → Neutral
Sep-16-16Downgrade Ladenburg Thalmann Buy → Neutral
Sep-16-16Downgrade JP Morgan Overweight → Neutral
Sep-16-16Downgrade Citigroup Buy → Neutral
Apr-04-16Initiated Chardan Capital Markets Neutral $5.75
Jul-09-15Reiterated Citigroup Buy $10 → $18
Jun-09-15Initiated Guggenheim Buy
Mar-11-14Reiterated Ladenburg Thalmann Buy $4 → $10
Oct-30-13Initiated FBR Capital Outperform $11
Sep-25-13Reiterated MLV & Co Buy $8.50 → $9.50
Mar-15-11Initiated Wedbush Outperform $6
Jun-15-10Initiated Dawson James Buy $4.50
Mar-15-10Initiated Roth Capital Buy $5
Dec-03-09Initiated Global Hunter Securities Buy $7.25
Dec-01-09Initiated Piper Jaffray Overweight $4.50
Nov-05-09Initiated Merriman Buy $7
Sep-19-17 04:05PM  Novavax to Present at the Ladenburg Thalmann 2017 Healthcare Conference GlobeNewswire
09:06AM  Novavax Initiates Phase 1/2 Trial of NanoFlu(TM) Vaccine in Older Adults GlobeNewswire
09:05AM  Novavax Initiates Phase 1/2 Trial of NanoFlu Vaccine in Older Adults GlobeNewswire
Sep-05-17 09:38PM  ETFs with exposure to Novavax, Inc. : September 6, 2017 Capital Cube
04:05PM  Novavax to Participate in the Citi 12th Annual Biotech Conference GlobeNewswire
08:00AM  Today's Research Reports on Trending Tickers: DryShips Inc. and Seadrill Ltd. ACCESSWIRE
Sep-01-17 08:25AM  3 Stocks That Could Soar More Than Amazon Motley Fool
Aug-25-17 05:04PM  ETFs with exposure to Novavax, Inc. : August 25, 2017 Capital Cube
12:08PM  Better Buy: Inovio Pharmaceuticals, Inc. vs. Novavax, Inc. Motley Fool
Aug-23-17 07:01AM  Novavax' Preclinical Influenza Nanoparticle Study Published in Vaccine GlobeNewswire
Aug-19-17 12:03PM  3 Top Biotech Stocks Under $10 Motley Fool
Aug-16-17 09:58AM  Novavax, Inc. :NVAX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017 Capital Cube
Aug-15-17 03:02PM  The Hidden Gem in Novavax's Pipeline You'll Want to Watch Motley Fool
Aug-13-17 09:47PM  Edited Transcript of NVAX earnings conference call or presentation 8-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-12-17 02:51PM  Where Does Zika Virus Vaccine Research Stand Now? Benzinga
Aug-10-17 09:37AM  Can Novavax Stage A Comeback In Q4? One Analyst Thinks So Benzinga
Aug-09-17 11:32PM  Novavax reports 2Q loss Associated Press
Aug-08-17 04:06PM  Novavax Reports Second Quarter 2017 Financial Results GlobeNewswire
10:10AM  Investor Network: Novavax, Inc to Host Earnings Call ACCESSWIRE
Aug-07-17 06:26PM  Novavax, Inc. Value Analysis (NASDAQ:NVAX) : August 7, 2017 Capital Cube
Aug-01-17 04:06PM  Novavax to Host Conference Call and Webcast to Discuss Second Quarter 2017 Financial Results on August 8, 2017 GlobeNewswire
03:02PM  The Single Best Reason to Buy Novavax Stock Now Motley Fool
Jul-28-17 03:08PM  We Spoke With The Experts, And Learned The Secrets Behind Beating The Penny Stock Market Benzinga -5.92%
Jul-27-17 10:31AM  Novavax, Inc.: Buy the Dip? Motley Fool -6.42%
Jul-26-17 09:34AM  Novavax, Inc. breached its 50 day moving average in a Bearish Manner : NVAX-US : July 26, 2017 Capital Cube
Jul-25-17 12:35PM  Biotech Movers: Novavax Falls Again After New Data on RSV Vaccine Fails to Excite TheStreet.com -27.15%
12:27PM  Why Novavax, Inc Is Tanking Today Motley Fool
09:09AM  Novavax, Inc. (NVAX) Shares Tumble on Clinical Data; Cantor Analyst Jumps in SmarterAnalyst
08:28AM  Novavax CEO: 'We have a vaccine we like' American City Business Journals
08:00AM  Today's Research Reports on Stocks to Watch: Cytori Therapeutics and Novavax Accesswire
Jul-24-17 05:12PM  Why Novavax Stock Spiked Today Motley Fool
04:41PM  Is There Life Left In The Novavax Clinical Program? Benzinga
04:06PM  Novavax Announces Positive Topline Data from Phase 2 Older Adult Trial and Provides Path Forward for RSV F Vaccine Programs GlobeNewswire
07:00AM  Genocea Reports Positive Top-Line 12-Month Phase 2b Data for GEN-003 in Genital Herpes GlobeNewswire
Jul-23-17 08:40AM  3 Stocks Under $5 That Could Make You Rich Motley Fool
Jul-22-17 02:03PM  Should Investors Brace for Bad News From Novavax's Looming Clinical Update? Motley Fool
Jul-21-17 09:30AM  Reminder: Novavax to Host an RSV F Vaccine Update Conference Call and Webcast on July 24, 2017 at 4:30 PM PR Newswire
Jul-18-17 04:34PM  Why Rite Aid, Novavax, and RH Jumped Today Motley Fool +27.19%
12:17PM  Here's Why Novavax, Inc. Stock Popped Today Motley Fool
08:00AM  Today's Research Reports on Trending Tickers: Puma Biotechnology Inc. and Novavax Inc. Accesswire
Jul-17-17 04:30PM  Novavax to Host an RSV F Vaccine Update Conference Call and Webcast on July 24, 2017 at 4:30 PM PR Newswire
Jul-12-17 08:00AM  Why Novavax Stock Surged Higher in June Motley Fool
Jul-10-17 09:30AM  Zacks.com featured highlights: Ardelyx, Novavax, BioScrip, Layne Christensen and Resonant Zacks
Jul-07-17 09:40AM  Biotech Movers: Alexion, Arena, Novavax TheStreet.com
08:41AM  5 Breakout Stocks Offering Phenomenal Returns Zacks
Jun-08-17 08:00AM  Today's Research Reports on Stocks to Watch: Kite Pharma and Novavax Accesswire
Jun-07-17 11:12AM  These 2 Catalysts Are Behind Novavax, Inc.'s 12% Rise in May Motley Fool
08:26AM  Novavax stock surges 6% after release of full mid-stage vaccine trial results MarketWatch
08:05AM  Novavax RSV F Vaccine Phase 2 Clinical Trial Data in Women of Child Bearing Age Published in Vaccine PR Newswire
May-26-17 07:06AM  Can The Uptrend Continue for Novavax (NVAX)? Zacks
May-22-17 01:58PM  ETFs with exposure to Novavax, Inc. : May 22, 2017 Capital Cube
May-19-17 08:00AM  Today's Research Reports on Biotech Stocks to Watch: Novavax and Progenics Pharmaceuticals Accesswire
May-18-17 08:00AM  Novavax Financial Review, Analysts Target and Outlook Accesswire +5.83%
May-16-17 09:34AM  Biotech Movers: Akebia, Editas, Novavax TheStreet.com
08:08AM  Novavax, Inc. breached its 50 day moving average in a Bullish Manner : NVAX-US : May 16, 2017 Capital Cube
May-15-17 12:12PM  Here's What's Driving Up Novavax, Inc. Stock Again Today Motley Fool +9.00%
May-13-17 11:15PM  Edited Transcript of NVAX earnings conference call or presentation 8-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-11-17 05:16PM  ETFs with exposure to Novavax, Inc. : May 11, 2017 Capital Cube +10.93%
05:16PM  Here's What Is Pushing Up Novavax, Inc. Stock Today Motley Fool
08:07AM  Novavax Announces the Promotion of Dr. James F. Cummings to Vice President, Clinical Development and Translational Medicine GlobeNewswire
May-10-17 10:11AM  Novavax, Inc. :NVAX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 Capital Cube
May-09-17 03:17PM  Novavax shares jump on news of narrowed first-quarter losses American City Business Journals +15.68%
11:40AM  Novavax, Inc Is Rising Today, but You Should Still Stay Far Away Motley Fool
09:00AM  Edited Transcript of NVAX earnings conference call or presentation 8-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-08-17 04:41PM  Novavax reports 1Q loss Associated Press
04:13PM  Novavax Reports First Quarter 2017 Financial Results GlobeNewswire
04:05PM  Novavax Reports First Quarter 2017 Financial Results GlobeNewswire
11:00AM  Investor Network: Novavax, Inc. to Host Earnings Call Accesswire
May-01-17 04:55PM  No bonuses for Novavax following failed RSV vaccine trial American City Business Journals
04:12PM  ETFs with exposure to Novavax, Inc. : May 1, 2017 Capital Cube
11:13AM  Novavax to Host Conference Call to Discuss First Quarter 2017 Financial Results on May 8, 2017 GlobeNewswire
10:57AM  Novavax to Host Conference Call to Discuss First Quarter 2017 Financial Results on May 8, 2017 GlobeNewswire
Apr-19-17 02:28PM  ETFs with exposure to Novavax, Inc. : April 19, 2017 Capital Cube
Apr-11-17 09:30AM  Biotech Movers Trading Positive Ahead of Market's Open TheStreet.com
Apr-07-17 05:11PM  ETFs with exposure to Novavax, Inc. : April 7, 2017 Capital Cube
09:24AM  Down 12.5%: Is Novavax Stock Too Cheap To Ignore? Motley Fool
Apr-06-17 04:04PM  Valeant, DryShips Dont Escape Thursdays 52-Week Low Club 24/7 Wall St. -12.54%
07:30AM  Today's Research Reports on Biotech Stocks to Watch: Sarepta Therapeutics and Novavax Accesswire
Apr-05-17 04:04PM  Valeant, DryShips Plunge into Wednesdays 52-Week Low Club 24/7 Wall St. -11.21%
10:55AM  The Waiting Game Crushed Novavax, Inc. in March, Sending Shares Down 15% Motley Fool
08:47AM  Implied Volatility Surging for Novavax (NVAX) Stock Options Zacks
Mar-31-17 08:05AM  3 Companies That Might Not Live to See 2020 Motley Fool
Mar-27-17 04:02PM  ETFs with exposure to Novavax, Inc. : March 27, 2017 Capital Cube
09:30AM  Biotech Industry Continues to Provide Investors with Gains in 2017: Today's Reports on Peregrine Pharmaceuticals and Novavax Accesswire
06:55AM  The 6 Most Shorted Nasdaq Stocks 24/7 Wall St.
Mar-21-17 08:22AM  3 Beaten-Up Biotech Stocks: Are They Bargains? Motley Fool -7.58%
Mar-20-17 08:59AM  Novavax, Inc. :NVAX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Capital Cube
Mar-16-17 09:30AM  Trade Volume Can Speak a Lot About Momentum of a Stock Accesswire
Mar-14-17 02:50PM  Novavax, Inc. :NVAX-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
Mar-09-17 12:40PM  These 5 Stocks Under $10 Could Ignite Soon
07:47AM  These Popular Stocks Could Prove Toxic for Your Portfolio at Motley Fool
Mar-06-17 11:02AM  Why Novavax's Shares Marched Higher in February at Motley Fool
09:30AM  Biotech's Rally in 2017 Gaining Steam After President Trump's Speech: Today's Reports on BioScrip and Novavax Accesswire
Mar-03-17 01:04PM  NOVAVAX INC Financials
Feb-28-17 07:02PM  NOVAVAX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -7.36%
06:13PM  Here's Why Novavax, Inc.'s Share Price Went Down the Drain at Motley Fool
11:03AM  3 Stocks to Avoid in Biotech at Motley Fool
10:10AM  Novavax: 'We still expect to enjoy the advantage of being the first RSV vaccine' at bizjournals.com
09:45AM  Novavax Stock Spikes on Q4 Results at Investopedia
09:22AM  Biotech Premarket Movers: Cempra, Novavax, Ionis
Novavax, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of recombinant nanoparticle vaccines and adjuvants. The company develops respiratory syncytial virus fusion protein nanoparticle vaccine candidate for infants via maternal immunization in Phase III development stage; older adults in Phase II development stage; and children six months to five years of age in Phase I development stage. It also develops Ebola GP vaccine in Phase 1 clinical trial; preclinical programs for Zika virus; and seasonal influenza and a combination respiratory vaccine candidate, as well as other infectious disease vaccine candidates. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
YOUNG JAMES FDirectorAug 31Sale1.06175,000184,8700Sep 01 04:27 PM
PHILLIPS BARCLAY ASVP, Chief Financial OfficerJul 31Buy0.892,0571,83138,669Aug 01 05:26 PM
MCMANUS MICHAEL A JRDirectorMay 12Buy0.9720,00019,396277,590May 12 03:24 PM
MCMANUS MICHAEL A JRDirectorMay 11Buy0.8410,0008,400257,590May 11 03:42 PM
PHILLIPS BARCLAY ASVP, Chief Financial OfficerMay 11Buy0.8425,00020,95036,612May 11 10:45 AM
Erck Stanley CPresident and CEOMay 11Buy0.8450,00041,980128,279May 11 10:29 AM
DOUGLAS RICHARDDirectorMay 11Buy0.93200,000185,780550,000May 12 09:59 AM
YOUNG JAMES FDirectorMar 14Sale1.39100,000138,980175,000Mar 16 04:19 PM
Trizzino JohnSVP, Commercial OperationsJan 31Buy1.123,4013,80988,965Feb 02 04:13 PM
Herrmann John A IIISVP, General CounselJan 31Buy1.124,9605,5557,072Feb 02 04:12 PM
PHILLIPS BARCLAY ASVP, Chief Financial OfficerJan 31Buy1.121,6331,82911,612Feb 02 04:10 PM
Glenn Gregory MPresident, R&DDec 07Buy1.451,0001,4464,427Dec 07 04:29 PM
Trizzino JohnSVP, Commercial OperationsSep 22Buy2.1746,00099,82085,564Sep 23 05:21 PM
DOUGLAS RICHARDDirectorSep 21Buy1.72100,000172,010350,000Sep 22 04:26 PM
MCMANUS MICHAEL A JRDirectorSep 21Buy1.6130,00048,297247,590Sep 22 04:24 PM
Glenn Gregory MPresident, R&DSep 21Buy1.651,0001,6493,427Sep 22 04:20 PM